What’s the Risk to Multiple Sclerosis Patients During COVID-19?

Multiple Sclerosis
Print icon

Layering a potentially lethal virus like COVID-19 onto a diagnosis of multiple sclerosis (MS) can seem daunting, but strengthening the relationship with your specialist may be key to getting through.

Dr. Derek Smith, a neurologist with the Ayer Neuroscience Institute’s Multiple Sclerosis Center, part of Hartford HealthCare, said staying in close contact with your provider can help you continue following your tailored medication and treatment guidelines to help keep the chronic illness manageable.

“People should continue taking their prescriptions, especially any immunotherapies. If they have questions, the best resource is their healthcare provider,” Dr. Smith said. “One of the things we did when the pandemic hit is we carefully analyzed all the different therapies we’re giving people and came up with a risk assessment that is sort of tailored to individual circumstances.”

People with MS, he continued, often require varied elements of care that could include diagnostic imaging, intravenous treatments and physical therapy. Medications are designed to target the immune system, which means people with MS should be more closely monitored during the COVID-19 pandemic.

“In general, people with MS are not at any different risk from COVID than anybody else,” Dr. Smith said. “But, because we are using therapies that affect the immune system, there is concern in that regard. In addition, many people with MS are mobility impaired and now we’re further localized in terms of our travel.”

Hartford HealthCare’s Multiple Sclerosis Center team is also involved in national networks that are collecting information about the various risks that come with some MS treatments, including how they may decrease or increase patient risk of contracting COVID-19.

“We just don’t know yet,” he said of that risk. “MS centers throughout the country are sharing information in this regard and, hopefully, we’ll have a better idea soon. This will be very important when we come out of the other end of this.”

The Multiple Sclerosis Center, which has several locations across Connecticut providing care close to people’s homes, is accepting new patients and available for existing patients. For more information, click here.

Need to see your doctor? New Patient? For more information about Hartford HealthCare virtual health visits, click here.

Click here to schedule a virtual visit with a Hartford HealthCare-GoHealth Urgent care doctor. Find out more about COVID-19 antibody tests here.

Sign up for our “Coping with COVID” podcast series here.

Stay with Hartford HealthCare for everything you need to know about the coronavirus threat. Click here for information updated daily.

Questions? Call our 24-hour hotline (860.972.8100 or, toll-free, 833.621.0600). 

Get text alerts by texting 31996 with COVID19 in the message field.


What's New

Parkinson's Research

Research: Inhibiting Gene in Test Mice Can Quiet Parkinson’s Tremors

When University of California-San Diego (UCSD) scientists transformed brain cells into functioning neurons that restored dopamine, eliminating Parkinson’s disease motor symptoms in test mice, humans watched with anticipation. The research, “Reversing a model of Parkinson’s disease with in situ converted nigral neurons,” was published this summer in the journal Nature....

COVID Panic

How to Make it Through The Toughest Days of COVID-19

By Amanda Brill Licensed Clinical Social Worker Hartford HealthCare Chase Family Movement Disorders Center It’s entirely reasonable during a pandemic to feel more stressed, anxious, lonely and depressed than usual. Yet, despite the circumstances, some people seemed to be doing OK. Researchers wanted to know what they were or were...

Coronavirus

Here’s How Hartford HealthCare is Keeping Patients Safe

Extensive planning and protocols have been put into place across Hartford HealthCare to make sure it is safe for patients to come back for appointments or treatment at any hospital or satellite facility in the wake of the COVID-19 pandemic. The system, like others worldwide, shut its doors to most...